Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Current Opinion in Pulmonary Medicine|November 8, 2016
Anticholinergic drugs in asthma therapyMaria D'Amato, Carolina Vitale, Antonio Molino, et al.Current Opinion in Allergy and Clinical Immunology|August 13, 2016
Climate change, air pollution, and allergic respiratory diseases: an updateGennaro D'Amato, Carolina Vitale, Maurizia Lanza, et al.International Archives of Allergy and Immunology|May 18, 2005
Human hair: an unexpected source of cat allergen exposureGennaro Liccardi, Domingo Barber, Maria Russo, et al.Therapeutics and Clinical Risk Management|May 14, 2008
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthmaGennaro D'Amato, Antonello Salzillo, Amedeo Piccolo, et al.Current Allergy and Asthma Reports|March 26, 2018
How Do Storms Affect Asthma?Gennaro D'Amato, Isabella Annesi-Maesano, Adriano Vaghi, et al.Current Allergy and Asthma Reports|February 28, 2020
Prevention of Allergic Asthma with Allergen Avoidance Measures and the Role of ExposomeGennaro D'Amato, Olga Patricia Monge Ortega, Isabella Annesi-Maesano, et al.Minerva Medica|September 2, 2017
Asthma-COPD overlap syndrome: recent advances in diagnostic criteria and prognostic significanceClaudio Sorino, Nicola Scichilone, Maria D'Amato, et al.Genome Biology|July 25, 2006
Shuffling of cis-regulatory elements is a pervasive feature of the vertebrate lineageRemo Sanges, Eva Kalmar, Pamela Claudiani, et al.Recent Patents on Inflammation & Allergy Drug Discovery|December 17, 2008
A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthmaGennaro D'Amato, Amedeo Piccolo, Antonello Salzillo, et al.Current Drug Targets. Inflammation and Allergy|September 24, 2004
Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseasesGennaro D'Amato, Gennaro Liccardi, Paolo Noschese, et al.Pageof 10